dmist logo

Drug Misuse Statistics Scotland 2007

 

B Services and treatment for drugs misusers

Scottish Drug Misuse Database photo

B1 Scottish Drug Misuse Database

The Scottish Drug Misuse Database (SDMD) offers a profile of drug misusers based on reports submitted on individuals when they first attend a service for assessment of their drug misuse problems.

The information presented relates to new patients/clients. A ‘new’ patient/ client is defined as any person who, at the time of presenting, is not currently in contact with a service that provides specialist assessment of a client’s drug misuse care needs.

From April 2006 the new SMR25a form was introduced. Changes to the data collection mean that trend information cannot be presented and figures are not directly comparable with those previously published from the SMR24 form (see background information for further details on the changes).

It is important to note that the percentages quoted below are based on the number of individuals on which data for each specific question are available i.e. they are not based on the total number of individuals reported to the database. Further detail on ‘information available’ is provided within the tables.

Key Points 2006/07

Overview

  • In 2006/07, 12,222 ‘new’ individuals were reported to the Scottish Drugs Misuse database (SDMD). This corresponds to a rate of 253 per 100,000 of the Scottish population (Table B1.1).
  • The male attendance rate was more than twice the female attendance rate (354 per 100,000 population for males, 156 per 100,000 population for females) (Tables B1.2 and B1.3).
  • Of those reporting illicit drug use, 68% reported using heroin (6,756 individuals) (Tables B1.8 and B1.9).
  • Over half (58%) of those under the age of 25 years old reporting illicit drug use reported using heroin (Table B1.11).
  • Twenty-eight per cent of all individuals (for whom information is available) reported that they had injected in the month prior to seeking treatment. Forty-three per cent reported that they had never injected (Tables B1.21, B1.22 and B1.23).
  • Twenty-nine per cent of current injectors reported that they had shared needles/ syringes in the previous month (Tables B1.27 and B1.28).
  • Of current injectors: 61% reported that they had been tested for Hepatitis B; 63% for Hepatitis C and 58% for HIV prior to seeking treatment (Table B1.31).
  • Sixty-six per cent of individuals reported that more than a year had elapsed between the onset of problem drug use and treatment first being sought (Table B1.20).

Geographical profile

  • In 2006/07, of those reporting use of heroin, 24% (1,636 individuals) were resident in NHS Greater Glasgow & Clyde; 18% (1,186 individuals) were resident in NHS Lothian; 11% (757 individuals) were resident in NHS Fife; and 10% (649 individuals) were resident in NHS Grampian (Table B1.8).
  • Of those reporting cocaine use, 44% (470 individuals) were resident in NHS Greater Glasgow & Clyde; 14% (151 individuals) were resident in NHS Lothian; and 9% (97 individuals) were resident in NHS Lanarkshire (Table B1.8).
  • 504 individuals reported crack cocaine use in 2006/07. Of these individuals 40% (203 individuals) were resident in NHS Grampian; 25% (126 individuals) were resident in NHS Lothian; and 19% (95 individuals) were resident in NHS Greater Glasgow and Clyde (Table B1.8).

Additional points

Demographic profile

This section describes the demographic profile of ‘new’ individuals attending services.

  • The male: female attendance ratio in 2006/07 was 2:1. There was variation between age groups with the male: female ratio for those aged under 20 years close to 2:1 and for those aged 35-39 years old at 3:1 (Tables B1.2 and B1.3).
  • The median age of male clients reported to the SDMD was 30 years, whilst the median age of female clients reported was 28 years (Tables B1.1, B1.2, and B1.3).
  • Half of clients reported to the SDMD in 2006/07 were aged 30 years or over (Tables B1.1 and B1.4).
  • Almost all (96%) of the individuals reported to the SDMD in 2006/07 described their ethnicity as ‘white Scottish’ (Table B1.5).

Social profile

The personal circumstances of the drug user seeking treatment or advice from services can influence the individual’s motivation for seeking help and the extent to which the service can contribute to a change in drug taking behaviour. Information on employment status, current living arrangements and accommodation, source of funding and average amount spent on their drug use, and the individual’s current legal status are potentially relevant factors and are collected by the SDMD.

  • Two thirds (67%) of individuals in 2006/07 were unemployed, 14% of individuals were in paid or unpaid employment (including full time education and training), and 5% had never been employed (Table B1.33).
  • Two thirds (67%) of individuals said that their drug use was funded by benefits, 27% reported that they funded their drug use with crime, and 18% reported that their drug use was funded by debt (Table B1.34).
  • The average daily spend, in a ‘typical’ drug using day, for individuals who reported using heroin, was £34 (Table B1.36).
  • For individuals using cocaine, the average daily spend, in a ‘typical’ drug using day, was reported as £87 (Table B1.37).
  • Almost four fifths (79%) of individuals (who provided information) reported that they lived in owned or rented accommodation at the time of presentation, 14% reported that they were living in temporary or unstable accommodation and 2% reported that they were roofless (Table B1.40).
  • A fifth (22%) of individuals had previously been in prison (Table B1.42).
  • A third (31%) of individuals reported that they had dependent children under the age of 16 years (Table B1.39).

Clients’ sources of referral and co-occurring health issues

This section includes information on the main source of referral and reports issues that have led patients/clients to attend the service for their drug misuse problem.

  • A third (31%) of individuals in 2006/07 self-referred to services. A further 27% were referred by a general practitioner (Table B1.6).
  • Fifty-five per cent of individuals reported that drug-related physical health issues had led them to present to a service, in addition to their drug use. Forty-two per cent reported mental health problems as a co-occurring health issue, and 23% reported alcohol problems as a co-occurring health issue (Table B1.7).

Types of drugs individuals are using

The SDMD collects a range of information about the drugs that the patients/ clients have used in the past month.

  • Of those reporting illicit drug use, 68% reported using heroin (6,756 individuals), 32% reported using cannabis (3,231 individuals), 31% reported using diazepam (3,140 individuals), 11% reported using cocaine (1,076 individuals) and 5% reported using crack cocaine (504 individuals) (Tables B1.8 and B1.9).
  • Of the 6,756 individuals who reported heroin use, 94% (6,339 individuals) reported it as their main drug of misuse (Tables B1.8 and B1.10).
  • Of those individuals who reported heroin as their main drug of misuse, 33% reported additional illicit diazepam use, 20% reported using cannabis, 6% reported using crack cocaine, and 5% reported using cocaine (Table B1.12).
  • Seven per cent of individuals who reported illicit drug use had used dihydrocodeine (675 individuals) and the same proportion of individuals reporting illicit drug use had used methadone (7%, 718 individuals) (this figure does not include those receiving a prescription for methadone) (Tables B1.8 and B1.9).
  • Reports of ecstasy use were most common amongst those aged under 20 years old with 20% of this group (176 individuals) reporting the use of ecstasy in 2006/07. Cannabis and solvent use were more common in the under 15 years old age group; 81% of this age group reported cannabis use and 14% reported solvent use. Caution is advised in interpreting these figures because the number of individuals in the 15 years old and under age group reported to the database is relatively small. (Table B1.9).

Age at first use, problem recognition and seeking help

The time lags between the age when an individual first used an illicit drug, age at onset of problem, and age when (professional) help was sought provide an indication of the pathways through drug misuse.

  • The majority of individuals reported to the SDMD were in their teens when they first started using illicit drugs (including volatile substances and over the counter medicines),in their teens/early twenties when their drug use became a problem and in their twenties when they sought help (Tables B1.15, B1.16 and B1.17).
  • The length of time between the first use of illicit drugs and the onset of a problem varies from person to person. Two fifths (42%) reported that they did not perceive their drug use to be a problem until after five years of misuse. Fourteen per cent of individuals perceived it as a problem after less than one year (Table B1.18).
  • The time from the onset of the problem drug use until help was first sought also varied amongst individuals. A third (34%) of individuals reported that they first sought help less than a year after they perceived there to be a problem, 27% sought help after one to two years, 14% sought help after three to four years, whilst the remaining 25% waited five years or more before seeking help (Table B1.20).

Ways in which people take drugs

All patients/clients are asked whether they have ever injected and if so, whether they have done so in the past month prior to attending the service. Similar questions are also asked about sharing needles/syringes and sharing spoons/water/filters/solutions. These questions provide information about the numbers of individuals who have either used equipment previously used by someone else or lent to someone else equipment that they have already used.

  • The highest proportions of individuals reporting injecting in the previous month were found in the 20 to 29 years old age range; 33% of 20 to 24 year olds and 34% of 25 to 29 year olds reported injecting in the month prior to attending a service (Table B1.22).
  • Only 14% of individuals aged under 20 years old reported injecting in the previous month (Table B1.22).
  • Almost two fifths (37%) of the individuals who had injected reported that they were under 20 years old when they first injected. The youngest reported age for first injecting was 12 years old, the median age was 21 years old (Table B1.23).
  • Half of individuals reporting heroin use also reported that they injected the drug (Table B1.25).
  • Thirty-five per cent of individuals reporting heroin use reported taking it through injection only. Fifteen per cent reported administering the drug both by injection and by another method (e.g. smoking) (Table B1.24).

Alcohol profile

Patients/clients who present at a service for drug misuse are also asked to give details of their alcohol consumption, although it should be noted that this section is only completed for clients who have presented to a service for drug misuse.

  • Forty-four per cent of individuals reported having consumed alcohol in the past month (5,411 individuals) (Table B1.32).
  • Approximately a quarter of individuals (27%) who provided information on frequency of consumption reported drinking alcohol every day, a further 26% reported drinking alcohol one to two days a week and 14% reported drinking alcohol two to three days a month (Table B1.32).

Background Information

The Scottish Drugs Misuse Database (SDMD) offers a profile of drug misusers based on reports submitted on individuals who attended a service for assessment of their drug misuse problems. These reports are taken at the time the patient/client initially attends a service.

Data Collection

The analysis presented in this section is based on data collected through SMR25a returns. Annex B1.3 includes a sample copy of the form. In April 2006 ISD introduced the SMR25a assessment form to replace the SMR24 form which had been in use from 2001. The revised form reflects the need for more in-depth and focussed information on clients who present for treatment. The new dataset incorporates most of the information that was collected using SMR24 but also includes new information, including blood borne virus testing information, information on dependent children and alcohol profile. The SMR25a form is completed at the beginning of an individual’s care episode.

There have been a number of changes which mean that data submitted through SMR25a forms is not directly comparable with previously published analysis of SMR24 data. Firstly, services submit a form only for a client beginning a new episode of care, and therefore do not submit forms for clients who have been referred from another service. Also, General Practitioners do not submit the new SMR25a form but continue to submit SMR24 forms. General Practitioner data is not included in this analysis. These changes were required in order to prepare for future data collection developments (see Data Developments below) These differences in data collection mean that information is presented for the financial year 2006/07 only. These figures are not directly comparable with information previously published from the SDMD.

Data Developments

The SMR25a form currently collects data at the beginning of an individual’s care episode. Developments are underway to collect further information at set points in an individuals treatment and to collect discharge and transfer data. This will mean that clients can be tracked across time and, if they are transferred or receive shared care, across drug services. These developments aim to provide a greater depth of information on clients’ pathways through treatment.

Understanding the data

‘New’ patients/clients

The information presented relates to new patients/clients. The statistics do not reflect the total number of drug misusers seen by services during any period.

New patient/client

Any person who, at the time of presenting, is not currently in contact with a service that provides specialist assessment of a client’s drug misuse care needs.

The database neither collects information on the non-client work in which most specialist projects are involved nor measures the number of contacts nor the amount of time spent with clients. The data are usually recorded at or around the time of the initial assessment and so no measure of outcome is included.

Misuse of alcohol may be reported to the database but it should not be reported for clients presenting solely with an alcohol problem.

Matching new patients/clients

By means of matching on certain criteria (initial of first name, initial & 4th character of surname, date of birth and gender) an adjustment is made for the double counting of individuals who may have attended more than one service during the period. The accuracy of these matches cannot be guaranteed. This is, however, the most precise method of matching individuals given that full name and address is not provided to ISD. The terms "individuals" and "attendees" refer to new patients/clients who have been through the matching process.

Local area analysis and trends

Individuals have been included only once within each NHS board and council area of residence. However, they may appear in more than one area and as a result the sums of the NHS board and council area data will not equal the Scotland figure. Where data are presented at a national level individuals are counted only once in any year. This is true for all tables except table B1.43, which presents statistics on all valid forms received.

Within Ayrshire & Arran NHS Board some agencies continued to collect data using the Ayrshire Common Database based on the SMR24 form after the introduction of the SMR25a form in April 2006. As a result information is unavailable from some agencies for certain questions that are specific to SMR25a.

Background notes on client confidentiality and small numbers

Maintaining patient confidentiality is a fundamental principle in ISD’s work. We take particular care when providing tabular information which results in small numbers appearing in table cells. We are currently reviewing our procedures with the objective of implementing the confidentiality guidance published by the Office of National Statistics (ONS) in October 2006. In line with this review and to protect client confidentiality when publishing sensitive data we have revised our protocol on the treatment of small numbers for this year’s publication. The main points are as follows:

a) Client confidentiality.

  • Data tables are classified as sensitive either if the information within them is in itself sensitive, eg. numbers of heroin injectors, or of it can be combined with data from other sensitive tables to obtain information that might be used to disclose the identity of individuals, eg. age, sex.
  • If the data are sensitive and the total number of clients providing information is less than 40 and any individual category has a frequency below 5 then all individual entries are replaced by ‘z’. If the total is less than 5 then the total is replaced by ‘z’.
  • If the data are not sensitive and the total number of clients providing information is less than 40 and any individual categories has a frequency below 5 then that entry is replaced by ‘z’. If the total is less than 5 then it is presented but all individual entries must be less than 5 and are replaced by ‘z’s.

b) Small numbers:

  • This protocol applies to all data, irrespective of sensitivity.
  • If the total number of clients is very small so that the data within individual categories are not statistically meaningful then individual entries are replaced by ‘†’. The total is reported.

Supplementary information for some specific tables can be found in Annex B1.1.

Definitions of statistical terms and tests can be found in Annex B1.2.

Acknowledgements

The co-operation and assistance of the staff at all services contributing to the database are gratefully acknowledged.

Further information

Information on the Scottish Drug Misuse Database is available at: http://www.drugmisuse.isdscotland.org/sdmd/sdmd.htm

If you would like further information please contact the Substance Misuse Information Strategy Team at: substancemisuse@isd.csa.scot.nhs.uk.